These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

429 related articles for article (PubMed ID: 21710692)

  • 1. Frequent promoter hypermethylation of BRCA2, CDH13, MSH6, PAX5, PAX6 and WT1 in ductal carcinoma in situ and invasive breast cancer.
    Moelans CB; Verschuur-Maes AH; van Diest PJ
    J Pathol; 2011 Oct; 225(2):222-31. PubMed ID: 21710692
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Promoter hypermethylation in ductal carcinoma in situ of the male breast.
    Vermeulen MA; van Deurzen CHM; Doebar SC; de Leng WWJ; Martens JWM; van Diest PJ; Moelans CB
    Endocr Relat Cancer; 2019 Jun; 26(6):575-584. PubMed ID: 30921768
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RUNX3 inactivation by frequent promoter hypermethylation and protein mislocalization constitute an early event in breast cancer progression.
    Subramaniam MM; Chan JY; Soong R; Ito K; Ito Y; Yeoh KG; Salto-Tellez M; Putti TC
    Breast Cancer Res Treat; 2009 Jan; 113(1):113-21. PubMed ID: 18256927
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Promoter CpG island hypermethylation during breast cancer progression.
    Park SY; Kwon HJ; Lee HE; Ryu HS; Kim SW; Kim JH; Kim IA; Jung N; Cho NY; Kang GH
    Virchows Arch; 2011 Jan; 458(1):73-84. PubMed ID: 21120523
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GSTP1 promoter hypermethylation is an early event in breast carcinogenesis.
    Lee JS
    Virchows Arch; 2007 Jun; 450(6):637-42. PubMed ID: 17479284
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epigenetic progression of columnar cell lesions of the breast to invasive breast cancer.
    Verschuur-Maes AH; de Bruin PC; van Diest PJ
    Breast Cancer Res Treat; 2012 Dec; 136(3):705-15. PubMed ID: 23104224
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Screening of significantly hypermethylated genes in breast cancer using microarray-based methylated-CpG island recovery assay and identification of their expression levels.
    Lian ZQ; Wang Q; Li WP; Zhang AQ; Wu L
    Int J Oncol; 2012 Aug; 41(2):629-38. PubMed ID: 22581028
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of promoter hypermethylation detection in serum as a diagnostic tool for breast carcinoma in Korean women.
    Kim JH; Shin MH; Kweon SS; Park MH; Yoon JH; Lee JS; Choi C; Fackler MJ; Sukumar S
    Gynecol Oncol; 2010 Aug; 118(2):176-81. PubMed ID: 20466412
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Promoter hypermethylation may be an important mechanism of the transcriptional inactivation of ARRDC3, GATA5, and ELP3 in invasive ductal breast carcinoma.
    Wang D; Yang PN; Chen J; Zhou XY; Liu QJ; Li HJ; Li CL
    Mol Cell Biochem; 2014 Nov; 396(1-2):67-77. PubMed ID: 25148870
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Detection and clinical significance of Notch1 methylation in breast cancer and intraductal proliferative breast lesions].
    Zhang N; Sun ZZ; Li F; Cao YW; Zhao CX; Liang WH; Sun HP; Li HA; Fu XG
    Zhonghua Bing Li Xue Za Zhi; 2011 May; 40(5):324-9. PubMed ID: 21756827
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methylation of the TPEF- and PAX6-promoters is increased in early bladder cancer and in normal mucosa adjacent to pTa tumours.
    Hellwinkel OJ; Kedia M; Isbarn H; Budäus L; Friedrich MG
    BJU Int; 2008 Mar; 101(6):753-7. PubMed ID: 18070176
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of RASSF1A aberrant promoter hypermethylation in sputum from chronic smokers and ductal carcinoma in situ from breast cancer patients.
    Honorio S; Agathanggelou A; Schuermann M; Pankow W; Viacava P; Maher ER; Latif F
    Oncogene; 2003 Jan; 22(1):147-50. PubMed ID: 12527916
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Frequent aberrant DNA methylation of ABCB1, FOXC1, PPP2R2B and PTEN in ductal carcinoma in situ and early invasive breast cancer.
    Muggerud AA; Rønneberg JA; Wärnberg F; Botling J; Busato F; Jovanovic J; Solvang H; Bukholm I; Børresen-Dale AL; Kristensen VN; Sørlie T; Tost J
    Breast Cancer Res; 2010; 12(1):R3. PubMed ID: 20056007
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Promoter hypermethylation in male breast cancer: analysis by multiplex ligation-dependent probe amplification.
    Kornegoor R; Moelans CB; Verschuur-Maes AH; Hogenes MCh; de Bruin PC; Oudejans JJ; van Diest PJ
    Breast Cancer Res; 2012 Jul; 14(4):R101. PubMed ID: 22765268
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased hypermethylation of glutathione S-transferase P1, DNA-binding protein inhibitor, death associated protein kinase and paired box protein-5 genes in triple-negative breast cancer Saudi females.
    Hafez MM; Al-Shabanah OA; Al-Rejaie SS; Al-Harbi NO; Hassan ZK; Alsheikh A; Al Theyab AI; Aldelemy ML; Sayed-Ahmed MM
    Asian Pac J Cancer Prev; 2015; 16(2):541-9. PubMed ID: 25684485
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alternative methylation of intron motifs is associated with cancer-related gene expression in both canine mammary tumor and human breast cancer.
    Nam AR; Lee KH; Hwang HJ; Schabort JJ; An JH; Won SH; Cho JY
    Clin Epigenetics; 2020 Jul; 12(1):110. PubMed ID: 32693820
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Droplet digital PCR analysis of CDH13 methylation status in Slovak women with invasive ductal breast cancer.
    Baranová I; Samec M; Dvorská D; Šťastný I; Janíková K; Kašubová I; Hornáková A; Lukáčová E; Kapinová A; Biringer K; Halašová E; Danková Z
    Sci Rep; 2024 Jun; 14(1):14700. PubMed ID: 38926485
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic changes in intraductal breast cancer detected by comparative genomic hybridization.
    Kuukasjärvi T; Tanner M; Pennanen S; Karhu R; Kallioniemi OP; Isola J
    Am J Pathol; 1997 Apr; 150(4):1465-71. PubMed ID: 9095001
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of Slit2 promoter hypermethylation in tissue and serum samples from breast cancer patients.
    Kim GE; Lee KH; Choi YD; Lee JS; Lee JH; Nam JH; Choi C; Park MH; Yoon JH
    Virchows Arch; 2011 Oct; 459(4):383-90. PubMed ID: 21894562
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aberrant methylation of tumour suppressor genes WT1, GATA5 and PAX5 in hepatocellular carcinoma.
    Mžik M; Chmelařová M; John S; Laco J; Slabý O; Kiss I; Bohovicová L; Palička V; Nekvindová J
    Clin Chem Lab Med; 2016 Dec; 54(12):1971-1980. PubMed ID: 27171388
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.